Royalty Pharma PLC

NAS : RPRX

USA·Healthcare·Biotechnology·Class A

$60.96

+0.04 (+0.07%)Oct 16 close

Market Cap

$27.14B

Enterprise Value

$37.33B

P/E (TTM)

36.49

P/B

7.51

Net Cash / (Debt)

−$7.24B

52-Week Range

$36 — $64

5-Year Range

$24 — $64

Avg Volume (3M)

3.55M

ListingsNAS STU MEX

Royalty Pharma PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript

2022-09-15Conference Presentations

Read the full earnings transcript with Waltermetrics Pro

The complete transcript text is available to Pro members.